Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie · 2013
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Аннотация на английскомСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deville J-L, Flechon A, Bruyère F, Karsenty G, Guy L, Bastide C
Аннотация
AIM: To describe drugs used in the chemotherapy of testis and penis neoplasms.
MATERIAL: Bibliographical search was performed from the database Medline (National Library of Medicine, PubMed) and websites of the HAS and the ANSM. The search was focused on the characteristics, the mode of action, the efficiency and the side effects of the various drugs concerned.
RESULTS: Nowadays, the chemotherapy is perfectly codified in adjuvant treatment or in first-line treatment of metastatic testis cancer. A single dose of carboplatin for seminoma testicular (stage I) in adjuvant treatment situation is one of the latest advances. Concerning penis cancer, the optimal protocols validated by a high level of evidence are missing.
CONCLUSION: The chemotherapy in testis and penis neoplasms knew few advances in recent years. So, it is necessary to include patients in clinical research protocols.
MATERIAL: Bibliographical search was performed from the database Medline (National Library of Medicine, PubMed) and websites of the HAS and the ANSM. The search was focused on the characteristics, the mode of action, the efficiency and the side effects of the various drugs concerned.
RESULTS: Nowadays, the chemotherapy is perfectly codified in adjuvant treatment or in first-line treatment of metastatic testis cancer. A single dose of carboplatin for seminoma testicular (stage I) in adjuvant treatment situation is one of the latest advances. Concerning penis cancer, the optimal protocols validated by a high level of evidence are missing.
CONCLUSION: The chemotherapy in testis and penis neoplasms knew few advances in recent years. So, it is necessary to include patients in clinical research protocols.
Предметные рубрики MeSH
Antineoplastic Combined Chemotherapy ProtocolsBleomycinCarboplatinChemotherapy, AdjuvantCisplatinCryopreservationEtoposideFluorouracilHumansIfosfamideMaleMethotrexateNeoadjuvant TherapyNeoplasm MetastasisNeoplasms, Germ Cell and EmbryonalOrchiectomyPaclitaxelPenile NeoplasmsSpermatozoaTesticular NeoplasmsVinblastine